English ticker view

DMRA

DAMORA THERAPEUTICS INC

This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.

Full Korean data view Search another ticker

Current price

$30.155

Public comments

0

13F holding rows

28

Insider trade rows

0

Public comments

0

Ranked by current return where prices are available.

13F direction

26 / 1

New or increased positions vs reduced or sold positions.

Insider activity

0 buyers

Based on SEC Form 4 market purchase and sale rows.

Latest comments

Most recent public records

No public comment records are connected to this ticker yet.

SEC 13F

Institution holding changes

Barclays PLC

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Bank of America Corp.

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Goldman Sachs Group Inc.

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Ameriprise Financial Inc

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Vanguard Capital Management LLC

new · May 8, 2026

+16.4%

Filing price $25.90 · Current $30.155

Marshall Wace, LLP

new · May 14, 2026

+16.4%

Filing price $25.90 · Current $30.155

Millennium Management LLC

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Point72 Asset Management, L.P.

new · May 15, 2026

+16.4%

Filing price $25.90 · Current $30.155

Insider trades

SEC Form 4 summary

No insider summary is connected to this ticker yet.

Information only. WhenBuy summarizes public data and simple calculations. It is not a stock recommendation, and returns may not reflect dividends, taxes, FX rates, fees, splits, or exact trade timing.